Početna stranica2607 • HKG
add
Shanghai Pharmaceuticals Holding Co Ltd
Preth. zaklj. cijena
10,92 $
Dnevni raspon
10,80 $ - 10,94 $
Godišnji raspon
10,04 $ - 14,70 $
Tržišna kapitalizacija
63,77 mlr. HKD
Prosječna količina
5,26 mil.
P/E omjer
8,57
Prinos dividende
-
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (CNY) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 70,76 mlr. | 0,87 % |
Operativni troškovi | 4,98 mlr. | −11,04 % |
Neto dohodak | 1,33 mlr. | −13,56 % |
Neto profitabilnost | 1,88 | −14,55 % |
Zarada po dionici | — | — |
EBITDA | 2,66 mlr. | −5,30 % |
Efektivna porezna stopa | 23,81 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (CNY) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 45,03 mlr. | 21,13 % |
Ukupna imovina | 225,87 mlr. | 3,89 % |
Ukupne obveze | 140,57 mlr. | 3,87 % |
Ukupni kapital | 85,30 mlr. | — |
Dionice u optjecaju | 3,71 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,55 | — |
Povrat imovine | 2,55 % | — |
Povrat kapitala | 4,02 % | — |
Tok novca
Neto promjena novca
| (CNY) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 1,33 mlr. | −13,56 % |
Gotovina od poslovanja | −2,20 mlr. | 59,73 % |
Gotovina iz ulaganja | −972,94 mil. | −152,83 % |
Gotovina iz financiranja | 3,86 mlr. | 18,89 % |
Neto promjena novca | 690,99 mil. | 284,82 % |
Slobodan tok novca | −6,07 mlr. | 22,14 % |
Više
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Osnovano
18. sij 1994.
Web-lokacija
Zaposlenici
49.402
